It has been hypothesized that the inactivation of GSK3β and the consequent decrease in tau phosphorylation also contribute to the restoration of cognitive function caused by PDE5 inhibitors in AD mice (review in García-Osta et al., 2012) [207]. The gene discussed is MAPT; the disease is Alzheimer disease.